136 related articles for article (PubMed ID: 22045666)
21. [Contiguous gene deletion within chromosome arm 10q is associated with juvenile polyposis of infancy, reflecting cooperation between the BMPR1A and PTEN tumor-suppressor genes].
Delnatte C; Sanlaville D; Mougenot JF; Stoppa-Lyonnet D
Med Sci (Paris); 2006 Nov; 22(11):912-3. PubMed ID: 17101085
[No Abstract] [Full Text] [Related]
22. PTEN/MMAC1/TEP1 involvement in primary prostate cancers.
Pesche S; Latil A; Muzeau F; Cussenot O; Fournier G; Longy M; Eng C; Lidereau R
Oncogene; 1998 Jun; 16(22):2879-83. PubMed ID: 9671408
[TBL] [Abstract][Full Text] [Related]
23. Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers.
Krohn A; Seidel A; Burkhardt L; Bachmann F; Mader M; Grupp K; Eichenauer T; Becker A; Adam M; Graefen M; Huland H; Kurtz S; Steurer S; Tsourlakis MC; Minner S; Michl U; Schlomm T; Sauter G; Simon R; Sirma H
J Pathol; 2013 Sep; 231(1):130-41. PubMed ID: 23794398
[TBL] [Abstract][Full Text] [Related]
24. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.
Cairns P; Okami K; Halachmi S; Halachmi N; Esteller M; Herman JG; Jen J; Isaacs WB; Bova GS; Sidransky D
Cancer Res; 1997 Nov; 57(22):4997-5000. PubMed ID: 9371490
[TBL] [Abstract][Full Text] [Related]
25. Interstitial deletion of 10q23.1 and confirmation of three 10qdel syndromes.
Singh S; Aftimos S; George A; Love DR
Singapore Med J; 2011 Jul; 52(7):e143-6. PubMed ID: 21808946
[TBL] [Abstract][Full Text] [Related]
26. A new case with 10q23 interstitial deletion encompassing both PTEN and BMPR1A narrows the genetic region deleted in juvenile polyposis syndrome.
Hiljadnikova Bajro M; Sukarova-Angelovska E; Adélaïde J; Chaffanet M; Dimovski AJ
J Appl Genet; 2013 Feb; 54(1):43-7. PubMed ID: 22993021
[TBL] [Abstract][Full Text] [Related]
27. Altered PTEN function caused by deletion or gene disruption is associated with poor prognosis in rectal but not in colon cancer.
Bohn BA; Mina S; Krohn A; Simon R; Kluth M; Harasimowicz S; Quaas A; Bockhorn M; Izbicki JR; Sauter G; Marx A; Stahl PR
Hum Pathol; 2013 Aug; 44(8):1524-33. PubMed ID: 23465274
[TBL] [Abstract][Full Text] [Related]
28. Homozygous 10q23/PTEN deletion and its impact on outcome in glioblastoma: a prospective translational study on a uniformly treated cohort of adult patients.
Srividya MR; Thota B; Shailaja BC; Arivazhagan A; Thennarasu K; Chandramouli BA; Hegde AS; Santosh V
Neuropathology; 2011 Aug; 31(4):376-83. PubMed ID: 21134002
[TBL] [Abstract][Full Text] [Related]
29. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.
Vlietstra RJ; van Alewijk DC; Hermans KG; van Steenbrugge GJ; Trapman J
Cancer Res; 1998 Jul; 58(13):2720-3. PubMed ID: 9661880
[TBL] [Abstract][Full Text] [Related]
30. TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer.
Steurer S; Mayer PS; Adam M; Krohn A; Koop C; Ospina-Klinck D; Tehrani AA; Simon R; Tennstedt P; Graefen M; Wittmer C; Brors B; Plass C; Korbel J; Weischenfeldt J; Sauter G; Huland H; Tsourlakis MC; Minner S; Schlomm T
Eur Urol; 2014 Dec; 66(6):978-81. PubMed ID: 25015038
[TBL] [Abstract][Full Text] [Related]
31. The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression.
Grupp K; Boumesli R; Tsourlakis MC; Koop C; Wilczak W; Adam M; Sauter G; Simon R; Izbicki JR; Graefen M; Huland H; Steurer S; Schlomm T; Minner S; Quaas A
Int J Cancer; 2014 Sep; 135(6):1399-407. PubMed ID: 24510842
[TBL] [Abstract][Full Text] [Related]
32. Partial PTEN deletion is linked to poor prognosis in breast cancer.
Lebok P; Kopperschmidt V; Kluth M; Hube-Magg C; Özden C; B T; Hussein K; Mittenzwei A; Lebeau A; Witzel I; Wölber L; Mahner S; Jänicke F; Geist S; Paluchowski P; Wilke C; Heilenkötter U; Simon R; Sauter G; Terracciano L; Krech R; von d Assen A; Müller V; Burandt E
BMC Cancer; 2015 Dec; 15():963. PubMed ID: 26672755
[TBL] [Abstract][Full Text] [Related]
33. βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion.
Tsourlakis MC; Weigand P; Grupp K; Kluth M; Steurer S; Schlomm T; Graefen M; Huland H; Salomon G; Steuber T; Wilczak W; Sirma H; Simon R; Sauter G; Minner S; Quaas A
Am J Pathol; 2014 Mar; 184(3):609-17. PubMed ID: 24378408
[TBL] [Abstract][Full Text] [Related]
34. PTEN deletion is rare but often homogeneous in gastric cancer.
Mina S; Bohn BA; Simon R; Krohn A; Reeh M; Arnold D; Bokemeyer C; Sauter G; Izbicki JR; Marx A; Stahl PR
J Clin Pathol; 2012 Aug; 65(8):693-8. PubMed ID: 22639407
[TBL] [Abstract][Full Text] [Related]
35. In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in situ hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading.
Picanço-Albuquerque CG; Morais CL; Carvalho FL; Peskoe SB; Hicks JL; Ludkovski O; Vidotto T; Fedor H; Humphreys E; Han M; Platz EA; De Marzo AM; Berman DM; Lotan TL; Squire JA
Virchows Arch; 2016 May; 468(5):607-17. PubMed ID: 26861919
[TBL] [Abstract][Full Text] [Related]
36. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
[TBL] [Abstract][Full Text] [Related]
37. Distinct subtypes of genomic
Vidotto T; Tiezzi DG; Squire JA
Mol Cytogenet; 2018; 11():1. PubMed ID: 29308088
[TBL] [Abstract][Full Text] [Related]
38. [PTEN gene in triple-negative breast cancer].
Karseladze AI; Kulevich EE; Karseladze DA; Poddubnaia IV
Arkh Patol; 2010; 72(5):20-3. PubMed ID: 21313761
[TBL] [Abstract][Full Text] [Related]
39. A novel third type of recurrent NF1 microdeletion mediated by nonallelic homologous recombination between LRRC37B-containing low-copy repeats in 17q11.2.
Bengesser K; Cooper DN; Steinmann K; Kluwe L; Chuzhanova NA; Wimmer K; Tatagiba M; Tinschert S; Mautner VF; Kehrer-Sawatzki H
Hum Mutat; 2010 Jun; 31(6):742-51. PubMed ID: 20506354
[TBL] [Abstract][Full Text] [Related]
40. Comparison of chromosomal and array-based comparative genomic hybridization for the detection of genomic imbalances in primary prostate carcinomas.
Ribeiro FR; Henrique R; Hektoen M; Berg M; Jerónimo C; Teixeira MR; Lothe RA
Mol Cancer; 2006 Sep; 5():33. PubMed ID: 16952311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
